• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨髓增生异常综合征白血病进展的克隆起源。

The clonal origins of leukemic progression of myelodysplasia.

机构信息

Department of Computer Science, University of Toronto, Toronto, ON, Canada.

The Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, ON, Canada.

出版信息

Leukemia. 2017 Sep;31(9):1928-1935. doi: 10.1038/leu.2017.17. Epub 2017 Jan 16.

DOI:10.1038/leu.2017.17
PMID:28090092
Abstract

The genetics behind the progression of myelodysplasia to secondary acute myeloid leukemia (sAML) is poorly understood. In this study, we profiled somatic mutations and their dynamics using next generation sequencing on serial samples from a total of 124 patients, consisting of a 31 patient discovery cohort and 93 patients from two validation cohorts. Whole-exome analysis on the discovery cohort revealed that 29 of 31 patients carry mutations related to at least one of eight commonly mutated pathways in AML. Mutations in genes related to DNA methylation and splicing machinery were found in T-cell samples, which expand at the initial diagnosis of the myelodysplasia, suggesting their importance as early disease events. On the other hand, somatic variants associated with signaling pathways arise or their allelic burdens expand significantly during progression. Our results indicate a strong association between mutations in activated signaling pathways and sAML progression. Overall, we demonstrate that distinct categories of genetic lesions play roles at different stages of sAML in a generally fixed order.

摘要

骨髓增生异常综合征向继发性急性髓系白血病(sAML)进展的遗传学机制尚不清楚。在这项研究中,我们使用下一代测序技术对总共 124 名患者的连续样本进行了体细胞突变及其动态分析,其中包括 31 名患者的发现队列和来自两个验证队列的 93 名患者。对发现队列的全外显子组分析表明,31 名患者中的 29 名至少携带与 AML 中八个常见突变途径之一相关的突变。在初始骨髓增生异常诊断时,T 细胞样本中发现了与 DNA 甲基化和剪接机制相关的基因突变,这表明它们作为早期疾病事件的重要性。另一方面,与信号通路相关的体细胞变异在进展过程中出现或其等位基因负担显著增加。我们的结果表明,激活的信号通路中的突变与 sAML 进展之间存在很强的关联。总体而言,我们证明了不同类别的遗传病变在 sAML 的不同阶段以一般固定的顺序发挥作用。

相似文献

1
The clonal origins of leukemic progression of myelodysplasia.骨髓增生异常综合征白血病进展的克隆起源。
Leukemia. 2017 Sep;31(9):1928-1935. doi: 10.1038/leu.2017.17. Epub 2017 Jan 16.
2
Gene mutations and clonal architecture in myelodysplastic syndromes and changes upon progression to acute myeloid leukaemia and under treatment.骨髓增生异常综合征中的基因突变和克隆结构以及向急性髓系白血病进展和治疗过程中的变化。
Br J Haematol. 2018 Sep;182(6):830-842. doi: 10.1111/bjh.15461. Epub 2018 Jul 5.
3
A high occurrence of acquisition and/or expansion of C-CBL mutant clones in the progression of high-risk myelodysplastic syndrome to acute myeloid leukemia.高危骨髓增生异常综合征向急性髓系白血病进展过程中频繁获得和/或扩增 C-CBL 突变克隆。
Neoplasia. 2011 Nov;13(11):1035-42. doi: 10.1593/neo.111192.
4
Clonal architecture of secondary acute myeloid leukemia.继发性急性髓系白血病的克隆结构。
N Engl J Med. 2012 Mar 22;366(12):1090-8. doi: 10.1056/NEJMoa1106968. Epub 2012 Mar 14.
5
Heterogeneous patterns of CEBPalpha mutation status in the progression of myelodysplastic syndrome and chronic myelomonocytic leukemia to acute myelogenous leukemia.在骨髓增生异常综合征和慢性粒单核细胞白血病进展为急性髓系白血病过程中CEBPα突变状态的异质性模式。
Clin Cancer Res. 2005 Mar 1;11(5):1821-6. doi: 10.1158/1078-0432.CCR-04-1932.
6
Co-occurrence of cohesin complex and Ras signaling mutations during progression from myelodysplastic syndromes to secondary acute myeloid leukemia.在从骨髓增生异常综合征进展为继发性急性髓系白血病过程中黏连蛋白复合体与Ras信号通路突变的共同出现。
Haematologica. 2021 Aug 1;106(8):2215-2223. doi: 10.3324/haematol.2020.248807.
7
Clonal evolution revealed by whole genome sequencing in a case of primary myelofibrosis transformed to secondary acute myeloid leukemia.一例原发性骨髓纤维化转化为继发性急性髓系白血病中全基因组测序揭示的克隆进化
Leukemia. 2015 Apr;29(4):869-76. doi: 10.1038/leu.2014.289. Epub 2014 Sep 25.
8
[Research progress on mechanism of MDS transformation into AML].[骨髓增生异常综合征转化为急性髓系白血病的机制研究进展]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2011 Feb;19(1):254-9.
9
Distinct Patterns of Clonal Evolution Drive Myelodysplastic Syndrome Progression to Secondary Acute Myeloid Leukemia.不同的克隆进化模式驱动骨髓增生异常综合征向继发性急性髓系白血病进展。
Blood Cancer Discov. 2022 Jul 6;3(4):316-329. doi: 10.1158/2643-3230.BCD-21-0128.
10
Detectable FLT3-ITD or RAS mutation at the time of transformation from MDS to AML predicts for very poor outcomes.从骨髓增生异常综合征(MDS)转化为急性髓系白血病(AML)时可检测到的FLT3内部串联重复(FLT3-ITD)或RAS突变预示预后极差。
Leuk Res. 2015 Dec;39(12):1367-74. doi: 10.1016/j.leukres.2015.10.005. Epub 2015 Oct 19.

引用本文的文献

1
[Application of the variant allele frequency of myeloid-associated gene mutations in myelodysplastic syndrome].[髓系相关基因突变的变异等位基因频率在骨髓增生异常综合征中的应用]
Zhonghua Xue Ye Xue Za Zhi. 2025 Apr 14;46(4):372-376. doi: 10.3760/cma.j.cn121090-20240806-00293.
2
[Dynamic changes in genetic mutations in myelodysplastic neoplasms with progressive disease and leukemic transformation].[骨髓增生异常肿瘤伴疾病进展和白血病转化过程中基因突变的动态变化]
Zhonghua Xue Ye Xue Za Zhi. 2025 Mar 14;46(3):252-260. doi: 10.3760/cma.j.cn121090-20240708-00254.
3
Malignant progression of preleukemic disorders.

本文引用的文献

1
Genomic Classification and Prognosis in Acute Myeloid Leukemia.急性髓系白血病的基因组分类与预后
N Engl J Med. 2016 Jun 9;374(23):2209-2221. doi: 10.1056/NEJMoa1516192.
2
Molecular landscape of acute myeloid leukemia in younger adults and its clinical relevance.年轻成人急性髓系白血病的分子图谱及其临床相关性。
Blood. 2016 Jan 7;127(1):29-41. doi: 10.1182/blood-2015-07-604496. Epub 2015 Dec 10.
3
Clonal dynamics in a single AML case tracked for 9 years reveals the complexity of leukemia progression.在一个 AML 病例中进行了长达 9 年的克隆动力学研究,揭示了白血病进展的复杂性。
白血病前期疾病的恶性进展。
Blood. 2024 May 30;143(22):2245-2255. doi: 10.1182/blood.2023020817.
4
Mutations in myeloid transcription factors and activated signaling genes predict chronic myeloid leukemia outcomes.髓系转录因子和激活信号基因的突变可预测慢性髓性白血病的结局。
Blood Adv. 2024 May 28;8(10):2361-2372. doi: 10.1182/bloodadvances.2023012127.
5
Prognosis and risk factors for ASXL1 mutations in patients with newly diagnosed acute myeloid leukemia and myelodysplastic syndrome.新诊断的急性髓系白血病和骨髓增生异常综合征患者 ASXL1 突变的预后和风险因素。
Cancer Med. 2024 Jan;13(1):e6871. doi: 10.1002/cam4.6871. Epub 2023 Dec 26.
6
The Genetic Landscape of Myelodysplastic Neoplasm Progression to Acute Myeloid Leukemia.骨髓增生异常肿瘤向急性髓系白血病进展的遗传学特征。
Int J Mol Sci. 2023 Mar 17;24(6):5734. doi: 10.3390/ijms24065734.
7
The clinicopathologic significance of NPM1 mutation and ability to detect mutated NPM1 by immunohistochemistry in non-AML myeloid neoplasms.NPM1 突变的临床病理意义及免疫组织化学检测非 AML 髓系肿瘤中突变 NPM1 的能力。
Genes Chromosomes Cancer. 2023 Oct;62(10):573-580. doi: 10.1002/gcc.23139. Epub 2023 Apr 4.
8
[Risk factors for leukemia transformation in patients with myelodysplastic syndromes].[骨髓增生异常综合征患者白血病转化的危险因素]
Zhonghua Xue Ye Xue Za Zhi. 2022 Oct 14;43(10):818-825. doi: 10.3760/cma.j.issn.0253-2727.2022.10.004.
9
Navigating the contested borders between myelodysplastic syndrome and acute myeloid leukemia.探寻骨髓增生异常综合征与急性髓系白血病之间存在争议的界限。
Front Oncol. 2022 Oct 28;12:1033534. doi: 10.3389/fonc.2022.1033534. eCollection 2022.
10
Somatic mutations of activating signalling, transcription factor, and tumour suppressor are a precondition for leukaemia transformation in myelodysplastic syndromes.体细胞突变的激活信号、转录因子和肿瘤抑制因子是骨髓增生异常综合征向白血病转化的前提。
J Cell Mol Med. 2022 Dec;26(23):5901-5916. doi: 10.1111/jcmm.17613. Epub 2022 Nov 15.
Leukemia. 2016 Feb;30(2):295-302. doi: 10.1038/leu.2015.264. Epub 2015 Oct 1.
4
Targeted sequencing identifies patients with preclinical MDS at high risk of disease progression.靶向测序可识别疾病进展风险高的临床前期 MDS 患者。
Blood. 2015 Nov 19;126(21):2362-5. doi: 10.1182/blood-2015-08-663237. Epub 2015 Sep 21.
5
Association Between Mutation Clearance After Induction Therapy and Outcomes in Acute Myeloid Leukemia.诱导治疗后突变清除与急性髓系白血病预后的关联
JAMA. 2015 Aug 25;314(8):811-22. doi: 10.1001/jama.2015.9643.
6
Karyotype evolution and acquisition of FLT3 or RAS pathway alterations drive progression of myelodysplastic syndrome to acute myeloid leukemia.核型演变以及FLT3或RAS信号通路改变的获得促使骨髓增生异常综合征进展为急性髓系白血病。
Haematologica. 2015 Dec;100(12):e487-90. doi: 10.3324/haematol.2015.127985. Epub 2015 Aug 20.
7
Myelodysplastic Syndromes Diagnosis: What Is the Role of Molecular Testing?骨髓增生异常综合征的诊断:分子检测的作用是什么?
Curr Hematol Malig Rep. 2015 Sep;10(3):282-91. doi: 10.1007/s11899-015-0270-5.
8
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes.意义未明的克隆性造血及其与骨髓增生异常综合征的鉴别
Blood. 2015 Jul 2;126(1):9-16. doi: 10.1182/blood-2015-03-631747. Epub 2015 Apr 30.
9
Myelodysplastic syndromes, version 2.2015.骨髓增生异常综合征,2015年第2版
J Natl Compr Canc Netw. 2015 Mar;13(3):261-72. doi: 10.6004/jnccn.2015.0038.
10
Acute myeloid leukemia ontogeny is defined by distinct somatic mutations.急性髓系白血病的发生是由独特的体细胞突变所定义的。
Blood. 2015 Feb 26;125(9):1367-76. doi: 10.1182/blood-2014-11-610543. Epub 2014 Dec 30.